Leupaxin anticorps (N-Term)
-
- Antigène Voir toutes Leupaxin (LPXN) Anticorps
- Leupaxin (LPXN)
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Leupaxin est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Réactivité croisée
- Humain, Souris, Rat (Rattus)
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
- Attributs du produit
- LPXN (LDPL, LDLP, Leupaxin)
- Purification
- Purified by immunoaffinity chromatography.
- Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human LPXN, different from the related rat sequence by two amino acids, and from the related mouse sequence by three amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product LPXN Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
- Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
- Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 4°C/-20°C
-
- Antigène
- Leupaxin (LPXN)
- Autre désignation
- LPXN (LPXN Produits)
- Synonymes
- anticorps LDPL, anticorps 4933402K05Rik, anticorps A530083L21Rik, anticorps AV278559, anticorps MGC140379, anticorps leupaxin, anticorps hypothetical protein, anticorps Leupaxin, anticorps LPXN, anticorps Lpxn, anticorps lpxn, anticorps PAAG_03110, anticorps PGTG_11441
- UniProt
- O60711
-